SummitTX Capital »

SPDR S&P Pharmaceuticals shares owned by SummitTX Capital

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by SummitTX Capital from 13F filings

Historical chart of SummitTX Capital investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by SummitTX Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by SummitTX Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $843k 16k 54.09

More positions owned by SummitTX Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Warner Bros Discovery Com Ser A (WBD)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Asml Hldg Nv N Y Registry Shs (ASML)
MKS Instruments (MKSI)
State Str Spdr S&p Midcap 40 Utser1 S&pdcrp (MDY)
Griffon Corporation (GFF)
Meritage Homes Corporation (MTH)
Cabot Oil & Gas Corporation (CTRA)
Topbuild (BLD)
NVR (NVR)
Cisco Systems (CSCO)
Ge Aerospace Com New (GE)
NVIDIA Corporation (NVDA)

View all positions for SummitTX Capital

Top funds holding SPDR S&P Pharmaceuticals

Bank of America Corporation
Wells Fargo & Company
Kingsview Wealth Management
Morgan Stanley
Envestnet Asset Management
First Citizens Bank & Trust
Envestnet Portfolio Solutions
LPL Financial
Susquehanna International
Branch Banking & Trust Company
Cetera Investment Advisers
Private Advisor
Clark Capital Management Group
Two Sigma Investments
Citigroup

View all funds holding SPDR S&P Pharmaceuticals